tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

JPMorgan Chase Ceases Substantial Holding in Mesoblast

Story Highlights
JPMorgan Chase Ceases Substantial Holding in Mesoblast

Elevate Your Investing Strategy:

Mesoblast Limited ( (AU:MSB) ) has shared an announcement.

Mesoblast Limited, a company in the biotechnology sector, has announced that JPMorgan Chase & Co. and its affiliates have ceased to be substantial holders of its voting securities. This change involves various transactions and securities lending agreements handled by JPMorgan’s subsidiaries, impacting a significant number of ordinary shares. The cessation of JPMorgan as a substantial holder may influence Mesoblast’s shareholder dynamics and market perception.

The most recent analyst rating on (AU:MSB) stock is a Buy with a A$1.10 price target. To see the full list of analyst forecasts on Mesoblast Limited stock, see the AU:MSB Stock Forecast page.

More about Mesoblast Limited

Average Trading Volume: 5,755,814

Technical Sentiment Signal: Hold

Current Market Cap: A$2.06B

For an in-depth examination of MSB stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1